5:50 PM
Nov 05, 2013
 |  BC Extra  |  Financial News

Biocartis raises EUR 30 million in series E

Diagnostic company Biocartis S.A. (Lausanne, Switzerland) raised EUR 30 million ($40.5 million) from existing investors in a series E round. RMM; Debiopharm Group (Lausanne, Switzerland); PMV; Valiance; Johnson & Johnson Development Corp.,...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >